HCPCS Code Details - Q5106

HCPCS Level II Code
Miscellaneous Services (Temporary Codes)
HCPCS Code Q5106
Description

Long description:
Injection, epoetin alfa, biosimilar, (retacrit) (for non-esrd use), 1000 units

Short description:
Inj retacrit non-esrd use

HCPCS Modifier1
HCPCS Pricing indicator 51 - Drugs
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code D - Special coverage instructions apply
ASC payment group code Effective Jul 01, 2018 - This procedure is approved to be performed in an ambulatory surgical center.
BETOS2 code O1E - Other drugs
HCPCS Action code A - Add procedure or modifier code
Type of service 9 - Other medical items or services
Effective date Effective Jul 01, 2018
Date added Added Jul 01, 2018
HCPCS Coding Procedures

HCPCS Modifiers

In HCPCS Level II, modifiers are composed of two alpha or alphanumeric characters.

Example: E0260-NU - Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress
NU” identifies the hospital bed as new equipment

ASP Drug pricing - Q5106

Effective Code Dosage Payment
Limit
Vaccine AWP % Vaccine Limit Infusion AWP % DME infusion limit Blood AWP % Blood limit Clotting factor Note
January 1, 2019 - March 31, 2019 1000 UNITS 11.3609 - - - - - -
October 1, 2018 - December 31, 2018 1000 UNITS 11.6918 - - - - - -
July 1, 2018 - September 30, 2018 1000 UNITS 11.6918 - - - - - -

See also

  • HCPCS J0885 · Injection, epoetin alfa, (for non-esrd use), 1000 units

  • HCPCS J0886 · Injection, epoetin alfa, 1000 units (for esrd on dialysis)

  • HCPCS Q4081 · Injection, epoetin alfa, 100 units (for esrd on dialysis)

  • HCPCS Q5105 · Injection, epoetin alfa, biosimilar, (retacrit) (for esrd on dialysis), 100 units

  • HCPCS Q5107 · Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg


1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”